 |
| |
 
 Email
for more information
Company's
other products
Email
to a colleague
Printer
friendly format
|
|
Boehringer Ingelheim: Facility of the Year Award for Facility Integration
South/east facade of building.
To accommodate the growing number of development projects and promote the application of new technologies, Boehringer Ingelheim decided to create a new facility on its major R&D site in Biberach in the southern part of Germany. A central goal was to integrate all major functions for pharmaceutical development in one building to promote synergies, optimal communication, and seamless cooperation across the relevant disciplines. Modern and flexible GMP facilities for internationally acceptable manufacture of investigational medicinal products were required to support clinical trials phase I to IV. Planned as a development facility, maximum flexibility was of utmost importance to enable handling of a broad diversity of product types, batch sizes, potencies, and dosage forms. With a growing number of highly potent active compounds emerging from research, suitable areas were necessary for safe handling without compromising flexibility.
Isolator suite for highly potent compounds.
The solution of this variety of requirements was the construction of a new building which was commissioned in January 2006. On 9000 m² utilization area the building contains state-of-the-art formulation laboratories, pilot plants for solids and parenterals, GMP facilities, and office areas. Both building layout and the concept for technical support systems allow easy adaption to future needs and the implementation of new technologies.
Project Implementation
Boehringer Ingelheim Pharma GmbH & Co.KG, Biberach, Germany
General Planning
Henn Architekten, Munich, Germany
Pharmaceutical Processing
Advantage Business Media
|
|
|
|
|
